Legionellosis and biologic therapies

Respiratory Medicine

Volumn 108, Issue 8, 2014, Pages 1223-1228

  Bodro, M ^a,b   Carratala J ^a   Paterson, D L ^b  

^a HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^b UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Biologic therapies; Immunocompromised patients; Infection; Legionella; Tumour necrosis factor alpha inhibitors

Indexed keywords

ADALIMUMAB; ETANERCEPT; IMMUNOSUPPRESSIVE AGENT; INFLIXIMAB; MONOCLONAL ANTIBODY; RITUXIMAB; STEROID; BIOLOGICAL FACTOR;

ARTICLE; BACTERIAL PNEUMONIA; BIOLOGICAL THERAPY; DISEASE ASSOCIATION; HUMAN; INFLAMMATORY BOWEL DISEASE; LEGIONELLA PNEUMONIA; LEGIONNAIRE DISEASE; MEDICAL LITERATURE; MEDLINE; PNEUMONIA; PRIORITY JOURNAL; RHEUMATIC DISEASE; RHEUMATOID ARTHRITIS; SYSTEMATIC REVIEW; TREATMENT DURATION; TREATMENT OUTCOME; ADULT; ADVERSE EFFECTS; AGED; CHEMICALLY INDUCED; FEMALE; INFLAMMATORY BOWEL DISEASES; MALE; MIDDLE AGED; RHEUMATIC DISEASES; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, MONOCLONAL; BIOLOGICAL FACTORS; BIOLOGICAL THERAPY; FEMALE; HUMANS; INFLAMMATORY BOWEL DISEASES; LEGIONELLOSIS; MALE; MIDDLE AGED; RHEUMATIC DISEASES;

EID: 84906324469     PISSN: 09546111     EISSN: 15323064     Source Type: Journal    
DOI: 10.1016/j.rmed.2014.04.017     Document Type: Article

References (37)

1. W.G. Dixon, K. Watson, M. Lunt, K.L. Hyrich, A.J. Silman, and D.P. Symmons Rates of serious infection, including site-specific and bacterial intracellular infection, in rheumatoid arthritis patients receiving anti-tumor necrosis factor therapy: results from the British Society for Rheumatology Biologics Register Arthritis Rheum 54 2006 2368 2376
2. R.S. Wallis, M.S. Broder, J.Y. Wong, M.E. Hanson, and D.O. Beenhouwer Granulomatous infectious diseases associated with tumor necrosis factor antagonists Clin Infect Dis - Off Publ Infect Dis Soc Am 38 2004 1261 1265
3. G. Camussi, E. Albano, C. Tetta, and F. Bussolino The molecular action of tumor necrosis factor-alpha Eur J Biochem/FEBS 202 1991 3 14
4. C. Popa, M.G. Netea, and P. Barrera et al. Cytokine production of stimulated whole blood cultures in rheumatoid arthritis patients receiving short-term infliximab therapy Cytokine 30 2005 72 77
5. D.K. Blanchard, H. Friedman, T.W. Klein, and J.Y. Djeu Induction of interferon-gamma and tumor necrosis factor by Legionella pneumophila: augmentation of human neutrophil bactericidal activity J Leukoc Biol 45 1989 538 545
6. C. Nara, K. Tateda, and T. Matsumoto et al. Legionella-induced acute lung injury in the setting of hyperoxia: protective role of tumour necrosis factor-alpha J Med Microbiol 53 2004 727 733
7. F. Tubach, P. Ravaud, and D. Salmon-Ceron et al. Emergence of Legionella pneumophila pneumonia in patients receiving tumor necrosis factor-alpha antagonists Clin Infect Dis - Off Publ Infect Dis Soc Am 43 2006 e95 100
8. M.J. Perez-Sola, J. Torre-Cisneros, B. Perez-Zafrilla, L. Carmona, M.A. Descalzo, and J.J. Gomez-Reino Infections in patients treated with tumor necrosis factor antagonists: incidence, etiology and mortality in the BIOBADASER registry Med Clin 137 2011 533 540
9. A. Hofmann, Y. Beaulieu, F. Bernard, and P. Rico Fulminant legionellosis in two patients treated with infliximab for Crohn's disease: case series and literature review Can J Gastroenterol 23 2009 829 833
10. M. Ramos-Casals, P. Brito-Zeron, S. Munoz, and M.J. Soto A systematic review of the off-label use of biological therapies in systemic autoimmune diseases Medicine 87 2008 345 364
11. F. Beigel, M. Jurgens, and L. Filik et al. Severe Legionella pneumophila pneumonia following infliximab therapy in a patient with Crohn's disease Inflamm Bowel Dis 15 2009 1240 1244
12. N. Kaku, K. Yanagihara, and Y. Morinaga et al. Detection of Legionella pneumophila serogroup 1 in blood cultures from a patient treated with tumor necrosis factor-alpha inhibitor J Infect Chemother 19 2013 166 170
13. K. Eisendle, and P. Fritsch Fatal fulminant legionnaires' disease in a patient with severe erythodermic psoriasis treated with infliximab after long-term steroid therapy Br J Dermatol 152 2005 585 586
14. G.F. Li, M. Benucci, and R.A. Del Pneumonitis caused by Legionella pneumoniae in a patient with rheumatoid arthritis treated with anti-TNF-alpha therapy (infliximab) J Clin Rheumatol Pract Rep Rheum Musculoskelet Dis 11 2005 119 120
15. G. Mancini, L. Erario, and R. Gianfreda et al. Tuberculosis and Legionella pneumophila pneumonia in a patient receiving anti-tumour necrosis factor-alpha (anti-TNF-alpha) treatment Clin Microbiol Infect - Off Publ Eur Soc Clin Microbiol Infect Dis 13 2007 1036 1037
16. M.J. Wondergem, A.E. Voskuyl, and A.M.A. van A case of legionellosis during treatment with a TNFalpha antagonist Scand J Infect Dis 36 2004 310 311
17. S. Jinno, S. Pulido, and B.C. Pien First reported United States case of Legionella pneumophila serogroup 1 pneumonia in a patient receiving anti-tumor necrosis factor-alpha therapy Hawaii Med J 68 2009 109 112
18. G. Epping, d.V.P.D. van, and R. Hendrix Legionella pneumophila pneumonia in a pregnant woman treated with anti-TNF-alpha antibodies for Crohn's disease: a case report J Crohn's Colitis 4 2010 687 689
19. M. Aringer, F. Houssiau, and C. Gordon et al. Adverse events and efficacy of TNF-alpha blockade with infliximab in patients with systemic lupus erythematosus: long-term follow-up of 13 patients Rheumatology 48 2009 1451 1454
20. S. Kroesen, A.F. Widmer, A. Tyndall, and P. Hasler Serious bacterial infections in patients with rheumatoid arthritis under anti-TNF-alpha therapy Rheumatology 42 2003 617 621
21. A. Kohn, M. Daperno, and A. Armuzzi et al. Infliximab in severe ulcerative colitis: short-term results of different infusion regimens and long-term follow-up Aliment Pharmacol Ther 26 2007 747 756
22. C. Albert, F. Vandenbos, O. Brocq, D. Carles, and L. Euller-Ziegler Legionellosis in patient treated with infliximab Rev Med Intern 25 2004 167 168
23. T.C. Wuerz, O. Mooney, and Y. Keynan Legionella pneumophila serotype 1 pneumonia in patient receiving adalimumab Emerg Infect Dis 18 2012 1872 1874
24. H. Vinter, and H.I. Nielsen Legionella pneumonia in patients treated with infliximab Ugeskr Laeger 171 2009 247
25. P. Novas Vidal, S. González Díez, and J. Velasco Montes Legionella in a patient with rheumatoid arthritis receiving abatacept Reumatol Clin 5 2009 214 215
26. F. Lanternier, F. Tubach, and P. Ravaud et al. Incidence and risk factors of Legionella pneumophila pneumonia during anti-tumor necrosis factor therapy: a prospective French study Chest 144 2013 990 998
27. R.A. Hansen, G. Gartlehner, G.E. Powell, and R.S. Sandler Serious adverse events with infliximab: analysis of spontaneously reported adverse events Clin Gastroenterol Hepatol 5 2007 729 735
28. A. Strangfeld, M. Eveslage, and M. Schneider et al. Treatment benefit or survival of the fittest: what drives the time-dependent decrease in serious infection rates under TNF inhibition and what does this imply for the individual patient? Ann Rheum Dis 70 2011 1914 1920
29. K.L. Jacobson, M.H. Miceli, J.J. Tarrand, and D.P. Kontoyiannis Legionella pneumonia in cancer patients Med Baltim 87 2008 152 159
30. C. Gudiol, C. Garcia-Vidal, and N. Fernandez-Sabe et al. Clinical features and outcomes of Legionnaires' disease in solid organ transplant recipients Transpl Infect Dis 11 2009 78 82
31. C. Gudiol, R. Verdaguer, D.M. Angeles, A. Fernandez-Sevilla, and J. Carratala Outbreak of Legionnaires' disease in immunosuppressed patients at a cancer centre: usefulness of universal urine antigen testing and early levofloxacin therapy Clin Microbiol Infect 13 2007 1125 1128
32. N. Sopena, L. Pedro-Botet, L. Mateu, G. Tolschinsky, C. Rey-Joly, and M. Sabria Community-acquired legionella pneumonia in elderly patients: characteristics and outcome J Am Geriatr Soc 55 2007 114 119
33. D. Viasus, S. Di Yacovo, and C. Garcia-Vidal et al. Community-acquired Legionella pneumophila pneumonia: a single-center experience with 214 hospitalized sporadic cases over 15 years Med Baltim 92 2013 51 60
34. A. Mykietiuk, J. Carratala, and N. Fernandez-Sabe et al. Clinical outcomes for hospitalized patients with Legionella pneumonia in the antigenuria era: the influence of levofloxacin therapy Clin Infect Dis 40 2005 794 799
35. T. Shimada, Y. Noguchi, and J.L. Jackson et al. Systematic review and metaanalysis: urinary antigen tests for Legionellosis Chest 136 2009 1576 1585
36. FDA AERS database [accessed in October].
37. E.G. Favalli, F. Desiati, and F. Atzeni et al. Serious infections during anti-TNFalpha treatment in rheumatoid arthritis patients Autoimmun Rev 8 2009 266 273